Expression of toll-like receptors 3, 7, and 9 in peripheral blood mononuclear cells from patients with systemic lupus erythematosus

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Klonowska Szymczyk, Agnieszka ^a,b   Wolska, Anna ^a   Robak, Tadeusz ^a   Cebula Obrzut, Barbara ^a   Smolewski, Piotr ^a   Robak, Ewa ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; CD3 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; TLR3 PROTEIN, HUMAN; TLR7 PROTEIN, HUMAN; TLR9 PROTEIN, HUMAN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; BLOOD; CASE CONTROL STUDY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOLOGY; GENE EXPRESSION REGULATION; INNATE IMMUNITY; MENOPAUSE; METABOLISM; MONONUCLEAR CELL;

ADULT; AGED; ANTIGENS, CD3; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTES, MONONUCLEAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MENOPAUSE; MIDDLE AGED; T-LYMPHOCYTES; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 9;

EID: 84896995025     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/381418     Document Type: Article

References (49)

1. Crispín J. C., Liossis S.-N. C., Kis-Toth K., Lieberman L. A., Kyttaris V. C., Juang Y.-T., Tsokos G. C., Pathogenesis of human systemic lupus erythematosus: recent advances. Trends in Molecular Medicine 2010 16 2 47 57 2-s2.0-76349107593 10.1016/j.molmed.2009.12.005
2. Guggino G., Giardina A. R., Ciccia F., Triolo G., Dieli F., Sireci G., Are toll-like receptors and decoy receptors involved in the immunopathogenesis of systemic lupus erythematosus and lupus-like syndromes? Clinical and Developmental Immunology 2012 2012 5 2-s2.0-80053550874 10.1155/2012/135932 135932
3. Richez C., Blanco P., Rifkin I., Moreau J.-F., Schaeverbeke T., Role for toll-like receptors in autoimmune disease: the example of systemic lupus erythematosus. Joint Bone Spine 2011 78 2 124 130 2-s2.0-79952245823 10.1016/j.jbspin.2010.09.005
4. Hurst J., von Landenberg P., Toll-like receptors and autoimmunity. Autoimmunity Reviews 2008 7 3 204 208 2-s2.0-37649018614 10.1016/j.autrev.2007. 11.006
5. Schnare M., Barton G. M., Holt A. C., Takeda K., Akira S., Medzhitov R., Toll-like receptors control activation of adaptive immune responses. Nature Immunology 2001 2 10 947 950 2-s2.0-0034775153 10.1038/ni712 (Pubitemid 32976167)
6. Pasare C., Medzhitov R., Toll-like receptors: linking innate and adaptive immunity. Microbes and Infection 2004 6 15 1382 1387 2-s2.0-16644366474 10.1016/j.micinf.2004.08.018 (Pubitemid 41110581)
7. Krug A., Nucleic acid recognition receptors in autoimmunity. Handbook of Experimental Pharmacology 2008 183 129 151 2-s2.0-39349090624
8. Bijl M., Limburg P. C., Kallenberg C. G. M., New insights into the pathogenesis of systemic lupus erythematosus (SLE): the role of apoptosis. The Netherlands Journal of Medicine 2001 59 2 66 75 2-s2.0-0034908127 10.1016/S0300-2977(01)00131-0 (Pubitemid 32703742)
9. Papadimitraki E. D., Bertsias G. K., Boumpas D. T., Toll like receptors and autoimmunity: a critical appraisal. Journal of Autoimmunity 2007 29 4 310 318 10.1016/j.jaut.2007.09.001 (Pubitemid 47633153)
10. Rahman A. H., Eisenberg R. A., The role of toll-like receptors in systemic lupus erythematosus. Springer Seminars in Immunopathology 2006 28 2 131 143 2-s2.0-34247343697 10.1007/s00281-006-0034-3 (Pubitemid 46628482)
11. Pawar R. D., Patole P. S., Ellwart A., Lech M., Segerer S., Schlondorff D., Anders H.-J., Ligands to nucleic acid-specific toll-like receptors and the onset of lupus nephritis. Journal of the American Society of Nephrology 2006 17 12 3365 3373 2-s2.0-33845236216 10.1681/ASN.2006030263 (Pubitemid 44865279)
12. Hochberg M. C., Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis and Rheumatism 1997 40 9 1725 2-s2.0-0031229830
13. Liang M. H., Socher S. A., Roberts W. N., Esdaile J. M., Measurement of systemic lupus erythematosus activity in clinical research. Arthritis and Rheumatism 1988 31 7 817 825 2-s2.0-0024044872
14. Wolska A., Cebula-Obrzut B., Smolewski P., Robak T., Effects of Toll-like receptor 7 and Toll-like receptor 9 signaling stimulators and inhibitors on chronic lymphocytic leukemia cells ex vivo and their interactions with cladribine. Leukemia & Lymphoma 2013 54 6 1268 1278
15. Wu O., Chen G. P., Chen H., Li X. P., Xu J. H., Zhao S. S., Sheng J., Feng J. B., Cai J., Fang X. H., Zhang W. H., Li L. H., Zhang N., Li J., Li J. J., Pan F. M., Wang C. Z., Ye D. Q., The expressions of Toll-like receptor 9 and T-bet in circulating B and T cells in newly diagnosed, untreated systemic lupus erythematosus and correlations with disease activity and laboratory data in a Chinese population. Immunobiology 2009 214 5 392 402 2-s2.0-64049093899 10.1016/j.imbio.2008.10.004
16. Papadimitraki E. D., Choulaki C., Koutala E., Bertsias G., Tsatsanis C., Gergianaki I., Raptopoulou A., Kritikos H. D., Mamalaki C., Sidiropoulos P., Boumpas D. T., Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process. Arthritis and Rheumatism 2006 54 11 3601 3611 2-s2.0-33750953650 10.1002/art.22197 (Pubitemid 44737172)
17. Wong C. K., Wong P. T. Y., Tam L. S., Li E. K., Chen D. P., Lam C. W. K., Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus. Clinical and Experimental Immunology 2010 159 1 11 22 2-s2.0-70749147183 10.1111/j.1365-2249.2009.04036.x
18. Papadimitraki E. D., Tzardi M., Bertsias G., Sotsiou E., Boumpas D. T., Glomerular expression of toll-like receptor-9 in lupus nephritis but not in normal kidneys: Implications for the amplification of the inflammatory response. Lupus 2009 18 9 831 835 2-s2.0-67650600639 10.1177/0961203309103054
19. Komatsuda A., Wakui H., Iwamoto K., Ozawa M., Togashi M., Masai R., Maki N., Hatakeyama T., Sawada K., Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clinical and Experimental Immunology 2008 152 3 482 487 2-s2.0-43349094856 10.1111/j.1365-2249.2008.03646.x (Pubitemid 351661498)
20. Nakano S., Morimoto S., Suzuki J., Nozawa K., Amano H., Tokano Y., Takasaki Y., Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus. Rheumatology 2008 47 2 145 149 2-s2.0-38649102170 10.1093/rheumatology/kem327 (Pubitemid 351168222)
21. Migita K., Miyashita T., Maeda Y., Nakamura M., Yatsuhashi H., Kimura H., Ishibashi H., Eguchi K., Toll-like receptor expression in lupus peripheral blood mononuclear cells. Journal of Rheumatology 2007 34 3 493 500 2-s2.0-33847634336 (Pubitemid 46364003)
22. Lu Y.-S., Pu L.-Y., Li X.-C., Wang X.-H., Methylprednisolone inhibits activated CD4+ T cell survival promoted by toll-like receptor ligands. Hepatobiliary and Pancreatic Diseases International 2010 9 4 376 383 2-s2.0-77955642221
23. Karim M. Y., Immunodeficiency in the lupus clinic. Lupus 2006 15 3 127 131 2-s2.0-33646016280 10.1191/0961203306lu2282rr
24. Adler G., Cytokiny w pocza̧tkowych etapach odpowiedzi odpornościowej. Reumatologia 2009 47 4 230 235
25. Hrycaj P., Cieślak D., Zajȩcie układu krwiotwórczego w przebiegu tocznia rumieniowatego układowego. Reumatologia 2013 51 1 31 35
26. O'Mahony D. S., Pham U., Iyer R., Hawn T. R., Liles W. C., Differential constitutive and cytokine-modulated expression of human Toll-like receptors in primary neutrophils, monocytes, and macrophages. International Journal of Medical Sciences 2008 5 1 1 8 2-s2.0-38149014670
27. Sirén J., Pirhonen J., Julkunen I., Matikainen S., IFN- α regulates TLR-dependent gene expression of IFN- α IFN- β IL-28, and IL-29. Journal of Immunology 2005 174 4 1932 1937 2-s2.0-13544263585 (Pubitemid 40223933)
28. Looney R. J., B cell-Targeted therapies for systemic lupus erythematosus: an update on clinical trial data. Drugs 2010 70 5 529 540 2-s2.0-77949970200 10.2165/11535420-000000000-00000
29. Rönnblom L., Eloranta M. L., The interferon signature in autoimmune diseases. Current Opinion in Rheumatology 2013 25 2 248 253 10.1097/BOR. 0b013e32835c7e32
30. Baechler E. C., Batliwalla F. M., Karypis G., Gaffney P. M., Ortmann W. A., Espe K. J., Shark K. B., Grande W. J., Hughes K. M., Kapur V., Gregersen P. K., Behrens T. W., Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proceedings of the National Academy of Sciences of the United States of America 2003 100 5 2610 2615 2-s2.0-0344492212 10.1073/pnas.0337679100 (Pubitemid 36297546)
31. Elkon K. B., Stone V. V., Type I interferon and systemic lupus erythematosus. Journal of Interferon and Cytokine Research 2011 31 11 803 812 2-s2.0-80955139536 10.1089/jir.2011.0045
32. Costenbader K. H., Feskanich D., Stampfer M. J., Karlson E. W., Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis and Rheumatism 2007 56 4 1251 1262 2-s2.0-34247193197 10.1002/art.22510 (Pubitemid 46608650)
33. Mok C. C., Lau C. S., Ho C. T. K., Wong R. W. S., Do flares of systemic lupus erythematosus decline after menopause? Scandinavian Journal of Rheumatology 1999 28 6 357 362 2-s2.0-0033403795 (Pubitemid 30033049)
34. Young N. A., Friedman A., Kaffenberger B., Jarjour W. N., Estrogen stimulation of endosomal Toll-Like receptor expression lowers the threshold of activation in peripheral blood mononuclear cells and contributes to the gender bias of systemic lupus erythematosus. Arthritis & Rheumatism 2011 63 supplement 10 1425
35. Seillet C., Laffont S., Trémollières F., Rouquié N., Ribot C., Arnal J.-F., Douin-Echinard V., Gourdy P., Guéry J.-C., The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor α signaling. Blood 2012 119 2 454 464 2-s2.0-84855857588 10.1182/blood-2011-08-371831
36. Meier A., Chang J. J., Chan E. S., Pollard R. B., Sidhu H. K., Kulkarni S., Wen T. F., Lindsay R. J., Orellana L., Mildvan D., Bazner S., Streeck H., Alter G., Lifson J. D., Carrington M., Bosch R. J., Robbins G. K., Altfeld M., Sex differences in the Toll-like receptor-mediated response of plasmacytoid dendritic cells to HIV-1. Nature Medicine 2009 15 8 955 959 2-s2.0-68349131723 10.1038/nm.2004
37. Cunningham A. M., Naga O. S., Eudaly J. G., Scott J. L., Gilkeson G. S., Estrogen receptor alpha modulates Toll-like receptor signaling in murine lupus. Clinical Immunology 2012 144 1 12 10.1016/j.clim.2012.04.001
38. Myles A., Aggarwal A., Expression of toll-like receptors 2 and 4 is increased in peripheral blood and synovial fluid monocytes of patients with enthesitis-related arthritis subtype of juvenile idiopathic arthritis. Rheumatology 2011 50 3 481 488 2-s2.0-79952028034 10.1093/rheumatology/keq362 keq362
39. Ospelt C., Brentano F., Rengel Y., Stanczyk J., Kolling C., Tak P. P., Gay R. E., Gay S., Kyburz D., Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: Toll-like receptor expression in early and longstanding arthritis. Arthritis and Rheumatism 2008 58 12 3684 3692 2-s2.0-57349192121 10.1002/art.24140
40. Ciechomska M., Cant R., Finnigan J., van Laar J. M., O'Reilly S., Role of toll-like receptors in systemic sclerosis. Expert Reviews in Molecular Medicine 2013 15, article e9 17 10.1017/erm.2013.10
41. Akira S., Mammalian Toll-like receptors. Current Opinion in Immunology 2003 15 1 5 11 2-s2.0-0037290876 10.1016/S0952-7915(02)00013-4 (Pubitemid 35454185)
42. Reynolds J. M., Pappu B. P., Peng J., Martinez G. J., Zhang Y., Chung Y., Ma L., Yang X. O., Nurieva R. I., Tian Q., Dong C., Toll-like receptor 2 signaling in CD4+ T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease. Immunity 2010 32 5 692 702 2-s2.0-77952866513 10.1016/j.immuni.2010.04.010
43. Al Shamsi M., Shahin A., Iwakura Y., Lukic M. L., Mensah-Brown E. P., Pam3CSK(4) enhanced beta cell loss and diabetogenesis: the roles of IFN-gamma and IL-17. Clinical Immunology 2013 149 1 86 96 10.1016/j.clim.2013.06.001
44. Abu-Rish E. Y., Amrani Y., Browning M. J., Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF. Rheumatology 2013 52 7 1190 1201 10.1093/rheumatology/ket006
45. Theofilopoulos A. N., Gonzalez-Quintial R., Lawson B. R., Koh Y. T., Stern M. E., Kono D. H., Beutler B., Baccala R., Sensors of the innate immune system: their link to rheumatic diseases. Nature Reviews Rheumatology 2010 6 3 146 156 2-s2.0-77949264203 10.1038/nrrheum.2009.278
46. Koh Y. T., Scatizzi J. C., Gahan J. D., Role of nucleic acid-sensing TLRs in diverse autoantibody specificities and anti-nuclear antibody-producing B cells. The Journal of Immunology 2013 190 10 4982 4990
47. Hwang S. H., Lee H., Yamamoto M., B cell TLR7 expression drives anti-RNA autoantibody production and exacerbates disease in systemic lupus erythematosus-prone mice. Journal of Autoimmunity 2010 189 12 5786 5796 10.1016/j.jaut.2009.11.001
48. Barrat F. J., Meeker T., Chan J. H., Guiducci C., Coffmann R. L., Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms. European Journal of Immunology 2007 37 12 3582 3586 2-s2.0-37549066665 10.1002/eji.200737815
49. Pawar R. D., Ramanjaneyulu A., Kulkarni O. P., Lech M., Segerer S., Anders H.-J., Inhibition of Toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus. Journal of the American Society of Nephrology 2007 18 6 1721 1731 2-s2.0-34249915031 10.1681/ASN.2006101162 (Pubitemid 46870309)